According to Reuters report on June 29 local time, the Democratic Republic of the Congo announced on the evening of June 28 that the number of confirmed Ebola cases in the country had reached 1,274, including 360 deaths.
Since last month, a deadly Ebola outbreak has occurred in Congo (RDC). It is reported that this outbreak was caused by the Bundibugyo virus, one of the six known types of Ebola viruses. Currently, there are no approved drugs or vaccines for this disease.
According to Bloomberg, before the outbreak of this epidemic, since the Ebola case was discovered in Uganda in 2007, the BdD Ebola virus has only caused two known outbreaks, with a total of only 193 confirmed cases.
Public information indicates that Ebola is a serious and often fatal human disease. There are three different viruses known to cause large-scale Ebola outbreaks: Ebola virus, Sudan virus, and Bd virus.
The average fatality rate for Ebola disease is approximately 50%. In previous outbreaks, the fatality rate varied from 25% to 90%. The vaccines and treatments that have been approved so far are only applicable to one type of virus (Ebola virus). Vaccines and treatments for other viruses are currently being developed.
The incubation period for the disease, or the time from infection to the appearance of symptoms, is between 2 and 21 days. Symptoms of Ebola can appear suddenly, including fever, fatigue, discomfort, muscle pain, headache, and sore throat. Subsequently, vomiting, diarrhea, abdominal pain, rashes, as well as symptoms indicating damage to the kidneys and liver may occur. Effects on the central nervous system can lead to confusion, irritability, and aggression.
